Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Vaccinations01:51

Vaccinations

45.3K
Overview
45.3K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

5.2K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.2K
PPE Use in Healthcare Settings II: Doffing01:10

PPE Use in Healthcare Settings II: Doffing

1.1K
The sequence of removing or doffing PPE starts with the gloves, as they are the most contaminated. Next is removal of the face shield or goggles, as they would interfere with removing other PPE. Then remove the gown, followed by the mask or respirator. Perform hand hygiene between steps if hands become contaminated and immediately after removing all PPE. Generally, the outside front and sleeves of the isolation gown, the goggles or the mask, the respirator, and the face shield are contaminated.
1.1K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

156
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
156
Cancer Vaccines01:30

Cancer Vaccines

509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
PPE Use in Healthcare Settings I: Donning01:22

PPE Use in Healthcare Settings I: Donning

1.3K
Donning PPE must be completed before contact with the patient. This process protects from infectious agents. The sequence and action included in each donning are critical, and the steps must be systematic to avoid exposure to pathogens. The institutional policy also needs to be followed while donning PPE. The pre-donning preparations are gathering equipment, inspecting the PPE equipment for tears, holes, or damage, removing jewelry, removing any garments below the elbows, and tying the hair...
1.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

American heart journal·2026
Same author

Collagen fibril diameter quantification using interference confocal reflectance microscopy.

Biomedical optics express·2026
Same author

Use of AI for Nurse Practitioner Students to Practice Conversations With Vaccine-Hesitant Patients and Caregivers.

Nurse educator·2026
Same author

Development, characterization, and inter-laboratory validation of methylated human cell free DNA candidate reference materials.

Clinical epigenetics·2026
Same author

Correction: Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection.

Frontiers in immunology·2026
Same author

Neuroglial-Breast Cancer Crosstalk Shapes the Brain Metastatic Niche.

Cells·2026

相关实验视频

Updated: Sep 9, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.4K

俄勒冈州卫生保健人员对mRNA疫苗增强剂量的有效性,2021年1月至2023年6月

Madysen Schreiber1, Valerie L S Ocampo2, Alexia Zhang2

  • 1Oregon Health & Science University-Portland State University School of Public Health, 1810 SW 5th Ave, Portland, OR 97201.

American journal of infection control
|August 30, 2025
PubMed
概括
此摘要是机器生成的。

在俄勒冈州的医疗人员中,mRNA COVID-19疫苗的第三剂量对SARS-CoV-2感染具有62.6%的有效性. 这凸显了高风险群体保持最新的COVID-19疫苗接种的重要性.

关键词:
美国新出现的传染病医疗保健工作人员感染控制冠状病毒疫苗的有效性

更多相关视频

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.7K
In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D
08:15

In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D

Published on: December 9, 2022

1.9K

相关实验视频

Last Updated: Sep 9, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.4K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.7K
In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D
08:15

In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D

Published on: December 9, 2022

1.9K

科学领域:

  • 流行病学
  • 疫苗学
  • 公共卫生

背景情况:

  • 卫生保健人员 (HCP) 优先接受早期的SARS-CoV-2疫苗接种.
  • 实际疫苗有效性 (VE) 数据至关重要,特别是在高风险人群中.
  • 这项研究重点关注俄勒冈州的医疗保健人员,以评估mRNA COVID-19助推剂的有效性.

研究的目的:

  • 总结俄勒冈州符合条件的医疗保健工作者的社会人口特征.
  • 估计mRNA COVID-19疫苗增剂剂量的 VE.
  • 评估不同的人口群体的增强剂吸收率.

主要方法:

  • 采用了病例对照研究设计.
  • 病例是具有SARS-CoV-2阳性测试的医疗保健工作者;对照组具有阴性测试.
  • 调整关键共变量以估计VE的条件后勤回归.

主要成果:

  • 与初级疫苗接种相比,mRNA增剂显示VE为62. 6% (95% CI: 37. 6%, 77. 6%).
  • 在拥有大学学位,私人保险和收入较高的医疗保健工作者中,增强剂的吸收率更高.
  • 社会人口学因素影响了增强疫苗接种.

结论:

  • mRNA COVID-19 助推疫苗提供了对 HCP 感染的大量保护.
  • 建议保持最新的疫苗接种状态,以保持持续的保护.
  • 这些发现支持医疗机构继续开展疫苗接种工作.